Shandong Weigao Group Medical Polymer Co Ltd (1066.HK)
Company Info
Highlights
HK$25.67B
11.88
HK$3.52 - HK$6.40
HK$6.62
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of HK$10,000 in Shandong Weigao Group Medical Polymer Co Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Shandong Weigao Group Medical Polymer Co Ltd (1066.HK) returned 27.73% year-to-date (YTD) and 16.01% over the past 12 months. Over the past 10 years, 1066.HK returned 0.39% annually, underperforming the S&P 500 benchmark at 10.43%.
1066.HK
27.73%
8.53%
14.71%
16.01%
-12.25%
0.39%
^GSPC (Benchmark)
-3.70%
13.67%
-5.18%
9.18%
14.14%
10.43%
Monthly Returns
The table below presents the monthly returns of 1066.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 6.33% | 4.11% | 17.55% | -4.19% | 2.45% | 27.73% | |||||||
| 2024 | -34.17% | 1.60% | -4.13% | 9.43% | -14.61% | -16.53% | 6.18% | 11.65% | 27.44% | -11.86% | -7.22% | 1.78% | -37.10% |
| 2023 | 1.40% | -2.62% | -0.95% | 6.38% | -13.19% | -10.90% | -1.95% | -22.31% | -11.79% | 6.64% | 2.21% | 2.70% | -39.48% |
| 2022 | -1.95% | 12.79% | -22.03% | 0.48% | 3.32% | 5.66% | 7.46% | 9.18% | -1.31% | 3.40% | 4.81% | 13.05% | 34.18% |
| 2021 | -17.24% | -8.14% | 15.16% | 13.56% | -1.12% | 5.72% | -23.18% | -8.05% | 9.49% | -4.74% | -16.89% | -11.71% | -43.81% |
| 2020 | -0.54% | 8.07% | -2.39% | 20.61% | 14.72% | 27.14% | 14.67% | -8.12% | -14.70% | -2.15% | 7.08% | 9.23% | 89.85% |
| 2019 | 3.31% | 4.12% | 9.97% | 2.67% | -11.43% | 3.81% | 7.11% | 7.58% | -0.25% | 11.65% | 5.59% | -1.16% | 49.55% |
| 2018 | 1.76% | -7.60% | -2.24% | -7.46% | 39.46% | -17.00% | 8.11% | 23.83% | 4.04% | -9.31% | 4.85% | -13.04% | 13.40% |
| 2017 | -1.74% | -8.25% | 19.06% | 1.98% | 7.94% | 1.03% | 2.77% | -0.79% | -11.52% | 2.19% | -4.47% | 6.36% | 11.81% |
| 2016 | -6.94% | 0.81% | -1.20% | -5.47% | -4.50% | -0.14% | -1.82% | 15.94% | 3.59% | -2.69% | 6.90% | -3.36% | -0.95% |
| 2015 | -2.72% | 4.93% | 6.89% | 5.12% | -4.87% | -14.55% | -10.19% | 4.23% | -9.96% | 11.20% | 2.23% | -3.09% | -13.43% |
| 2014 | -13.00% | 8.79% | -10.71% | -11.76% | -3.33% | 0.94% | 6.34% | -2.48% | -2.17% | 1.82% | -11.74% | -8.88% | -39.55% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of 1066.HK is 65, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Shandong Weigao Group Medical Polymer Co Ltd (1066.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Shandong Weigao Group Medical Polymer Co Ltd provided a 3.49% dividend yield over the last twelve months, with an annual payout of HK$0.20 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | HK$0.20 | HK$0.20 | HK$0.17 | HK$0.17 | HK$0.18 | HK$0.20 | HK$0.13 | HK$0.11 | HK$0.10 | HK$0.09 | HK$0.09 | HK$0.08 |
Dividend yield | 3.49% | 4.46% | 2.19% | 1.34% | 1.80% | 1.15% | 1.34% | 1.75% | 1.82% | 1.73% | 1.72% | 1.25% |
Monthly Dividends
The table displays the monthly dividend distributions for Shandong Weigao Group Medical Polymer Co Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | |||||||
| 2024 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.10 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.10 | HK$0.00 | HK$0.00 | HK$0.20 |
| 2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.09 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.08 | HK$0.00 | HK$0.00 | HK$0.17 |
| 2022 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.08 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.10 | HK$0.00 | HK$0.00 | HK$0.17 |
| 2021 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.08 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.09 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.18 |
| 2020 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.07 | HK$0.00 | HK$0.00 | HK$0.13 | HK$0.00 | HK$0.00 | HK$0.20 |
| 2019 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.06 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.07 | HK$0.00 | HK$0.13 |
| 2018 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.06 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.06 | HK$0.11 |
| 2017 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.05 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.05 | HK$0.00 | HK$0.00 | HK$0.10 |
| 2016 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.04 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.05 | HK$0.00 | HK$0.09 |
| 2015 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.04 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.05 | HK$0.00 | HK$0.00 | HK$0.09 |
| 2014 | HK$0.04 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.04 | HK$0.00 | HK$0.08 |
Dividend Yield & Payout
Dividend Yield
Shandong Weigao Group Medical Polymer Co Ltd has a dividend yield of 3.49%, which is quite average when compared to the overall market.
Payout Ratio
Shandong Weigao Group Medical Polymer Co Ltd has a payout ratio of 41.44%, which is quite average when compared to the overall market. This suggests that Shandong Weigao Group Medical Polymer Co Ltd strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Shandong Weigao Group Medical Polymer Co Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Shandong Weigao Group Medical Polymer Co Ltd was 81.98%, occurring on Jul 2, 2024. The portfolio has not yet recovered.
The current Shandong Weigao Group Medical Polymer Co Ltd drawdown is 70.42%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -81.98% | Aug 6, 2020 | 959 | Jul 2, 2024 | — | — | — |
| -70.07% | Jul 23, 2007 | 297 | Oct 27, 2008 | 141 | May 25, 2009 | 438 |
| -62.96% | Dec 14, 2010 | 1345 | Jun 1, 2016 | 924 | Mar 3, 2020 | 2269 |
| -22.24% | May 5, 2010 | 19 | Jun 1, 2010 | 53 | Aug 17, 2010 | 72 |
| -21.85% | Mar 6, 2020 | 12 | Mar 23, 2020 | 18 | Apr 20, 2020 | 30 |
Volatility
Volatility Chart
The current Shandong Weigao Group Medical Polymer Co Ltd volatility is 15.12%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Shandong Weigao Group Medical Polymer Co Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Shandong Weigao Group Medical Polymer Co Ltd, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -100.0%.
Valuation
The Valuation section provides an overview of how Shandong Weigao Group Medical Polymer Co Ltd is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for 1066.HK, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, 1066.HK has a P/E ratio of 11.9. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for 1066.HK compared to other companies in the Medical Instruments & Supplies industry. 1066.HK currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 1066.HK relative to other companies in the Medical Instruments & Supplies industry. Currently, 1066.HK has a P/S ratio of 2.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 1066.HK in comparison with other companies in the Medical Instruments & Supplies industry. Currently, 1066.HK has a P/B value of 1.0. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |